PD 29875
Alternative Names: 225Ac-PD-29875; PD-29875Latest Information Update: 15 Jan 2025
Price :
$50 *
At a glance
- Originator PeptiDream
- Class Antineoplastics; Cyclic peptides; Macrocyclic compounds; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Gastric cancer
Most Recent Events
- 12 Dec 2024 Preclinical trials in Gastric cancer in Japan (unspecified route)